Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-14

Clinical Trial Update: Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease [NA]

View source ↗

Summary

A UCSF-sponsored trial examining napping, sleep and cognitive decline related to Alzheimer's disease was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Sleep, Alzheimer Disease | NA | Status: TERMINATED | Results posted: 2025-11-14